Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Dose tapering for ciclosporin in cats with nonflea‐induced hypersensitivity dermatitis

Identifieur interne : 001087 ( Main/Curation ); précédent : 001086; suivant : 001088

Dose tapering for ciclosporin in cats with nonflea‐induced hypersensitivity dermatitis

Auteurs : Jean Steffan ; Elizabeth Roberts ; Andrea Cannon ; Pascal Prélaud ; Peter Forsythe ; Jacques Fontaine ; Stephen King ; Wolfgang Seewald

Source :

RBID : PMC:7169265

Abstract

Background

Little information is available on the ciclosporin dose‐tapering regimen and clinical response in the treatment of feline hypersensitivity dermatitis.

Hypothesis/Objectives

To test a dose‐tapering regimen and assess efficacy and clinical safety for up to 18 weeks.

Animals

Eighty‐eight client‐owned cats with feline hypersensitivity dermatitis.

Methods

Cats that received either a placebo or ciclosporin at 2.5 mg/kg or 7 mg/kg daily for 6 weeks were given 7 mg/kg ciclosporin daily for 4 weeks. Depending on the clinical response, the dose was tapered from daily to every other day over the next 4 weeks and further to twice a week for an additional 4 weeks.

Results

After all cats received 7 mg/kg for 4 weeks, the dose could be tapered to every other day for the next 4 weeks in 70% of cats remaining in the study. During the next 4 weeks, 57, 15 and 22% of cats remaining in the study could be treated at twice a week, every other day or daily, respectively. After the first 4 weeks, the mean lesion score and owner‐assessed pruritus improved over baseline by 69 and 61%, respectively, and remained stable during the following 8 weeks. Approximately 65% of the cats in the study were reported to have an adverse event (AE), very often mild and resolving spontaneously. The most frequent AEs were gastrointestinal and included primarily vomiting and diarrhoea. Eighty per cent of AEs occurred when cats were on daily treatment.

Conclusions and clinical importance

Results suggest that the induction dose of 7 mg/kg ciclosporin can be tapered as soon as 4 weeks without deterioration of the clinical response. Establishment of the lowest effective dosing regimen of ciclosporin reduced the frequency of AEs.


Url:
DOI: 10.1111/vde.12018
PubMed: 23530522
PubMed Central: 7169265

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:7169265

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Dose tapering for ciclosporin in cats with nonflea‐induced hypersensitivity dermatitis</title>
<author>
<name sortKey="Steffan, Jean" sort="Steffan, Jean" uniqKey="Steffan J" first="Jean" last="Steffan">Jean Steffan</name>
<affiliation>
<nlm:aff id="vde12018-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Roberts, Elizabeth" sort="Roberts, Elizabeth" uniqKey="Roberts E" first="Elizabeth" last="Roberts">Elizabeth Roberts</name>
<affiliation>
<nlm:aff id="vde12018-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cannon, Andrea" sort="Cannon, Andrea" uniqKey="Cannon A" first="Andrea" last="Cannon">Andrea Cannon</name>
<affiliation>
<nlm:aff id="vde12018-aff-0003"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Prelaud, Pascal" sort="Prelaud, Pascal" uniqKey="Prelaud P" first="Pascal" last="Prélaud">Pascal Prélaud</name>
<affiliation>
<nlm:aff id="vde12018-aff-0004"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Forsythe, Peter" sort="Forsythe, Peter" uniqKey="Forsythe P" first="Peter" last="Forsythe">Peter Forsythe</name>
<affiliation>
<nlm:aff id="vde12018-aff-0005"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Fontaine, Jacques" sort="Fontaine, Jacques" uniqKey="Fontaine J" first="Jacques" last="Fontaine">Jacques Fontaine</name>
<affiliation>
<nlm:aff id="vde12018-aff-0006"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="King, Stephen" sort="King, Stephen" uniqKey="King S" first="Stephen" last="King">Stephen King</name>
<affiliation>
<nlm:aff id="vde12018-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Seewald, Wolfgang" sort="Seewald, Wolfgang" uniqKey="Seewald W" first="Wolfgang" last="Seewald">Wolfgang Seewald</name>
<affiliation>
<nlm:aff id="vde12018-aff-0001"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">23530522</idno>
<idno type="pmc">7169265</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169265</idno>
<idno type="RBID">PMC:7169265</idno>
<idno type="doi">10.1111/vde.12018</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">000838</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000838</idno>
<idno type="wicri:Area/Pmc/Curation">000838</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000838</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000843</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000843</idno>
<idno type="wicri:Area/Ncbi/Merge">000568</idno>
<idno type="wicri:Area/Ncbi/Curation">000568</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000568</idno>
<idno type="wicri:doubleKey">0959-4493:2013:Steffan J:dose:tapering:for</idno>
<idno type="wicri:Area/Main/Merge">001088</idno>
<idno type="wicri:Area/Main/Curation">001087</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Dose tapering for ciclosporin in cats with nonflea‐induced hypersensitivity dermatitis</title>
<author>
<name sortKey="Steffan, Jean" sort="Steffan, Jean" uniqKey="Steffan J" first="Jean" last="Steffan">Jean Steffan</name>
<affiliation>
<nlm:aff id="vde12018-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Roberts, Elizabeth" sort="Roberts, Elizabeth" uniqKey="Roberts E" first="Elizabeth" last="Roberts">Elizabeth Roberts</name>
<affiliation>
<nlm:aff id="vde12018-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cannon, Andrea" sort="Cannon, Andrea" uniqKey="Cannon A" first="Andrea" last="Cannon">Andrea Cannon</name>
<affiliation>
<nlm:aff id="vde12018-aff-0003"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Prelaud, Pascal" sort="Prelaud, Pascal" uniqKey="Prelaud P" first="Pascal" last="Prélaud">Pascal Prélaud</name>
<affiliation>
<nlm:aff id="vde12018-aff-0004"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Forsythe, Peter" sort="Forsythe, Peter" uniqKey="Forsythe P" first="Peter" last="Forsythe">Peter Forsythe</name>
<affiliation>
<nlm:aff id="vde12018-aff-0005"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Fontaine, Jacques" sort="Fontaine, Jacques" uniqKey="Fontaine J" first="Jacques" last="Fontaine">Jacques Fontaine</name>
<affiliation>
<nlm:aff id="vde12018-aff-0006"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="King, Stephen" sort="King, Stephen" uniqKey="King S" first="Stephen" last="King">Stephen King</name>
<affiliation>
<nlm:aff id="vde12018-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Seewald, Wolfgang" sort="Seewald, Wolfgang" uniqKey="Seewald W" first="Wolfgang" last="Seewald">Wolfgang Seewald</name>
<affiliation>
<nlm:aff id="vde12018-aff-0001"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Veterinary Dermatology</title>
<idno type="ISSN">0959-4493</idno>
<idno type="eISSN">1365-3164</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="vde12018-sec-0001">
<title>Background</title>
<p>Little information is available on the ciclosporin dose‐tapering regimen and clinical response in the treatment of feline hypersensitivity dermatitis.</p>
</sec>
<sec id="vde12018-sec-0002">
<title>Hypothesis/Objectives</title>
<p>To test a dose‐tapering regimen and assess efficacy and clinical safety for up to 18 weeks.</p>
</sec>
<sec id="vde12018-sec-0003">
<title>Animals</title>
<p>Eighty‐eight client‐owned cats with feline hypersensitivity dermatitis.</p>
</sec>
<sec id="vde12018-sec-0004">
<title>Methods</title>
<p>Cats that received either a placebo or ciclosporin at 2.5 mg/kg or 7 mg/kg daily for 6 weeks were given 7 mg/kg ciclosporin daily for 4 weeks. Depending on the clinical response, the dose was tapered from daily to every other day over the next 4 weeks and further to twice a week for an additional 4 weeks.</p>
</sec>
<sec id="vde12018-sec-0005">
<title>Results</title>
<p>After all cats received 7 mg/kg for 4 weeks, the dose could be tapered to every other day for the next 4 weeks in 70% of cats remaining in the study. During the next 4 weeks, 57, 15 and 22% of cats remaining in the study could be treated at twice a week, every other day or daily, respectively. After the first 4 weeks, the mean lesion score and owner‐assessed pruritus improved over baseline by 69 and 61%, respectively, and remained stable during the following 8 weeks. Approximately 65% of the cats in the study were reported to have an adverse event (
<styled-content style="fixed-case" toggle="no">AE</styled-content>
), very often mild and resolving spontaneously. The most frequent
<styled-content style="fixed-case" toggle="no">AE</styled-content>
s were gastrointestinal and included primarily vomiting and diarrhoea. Eighty per cent of
<styled-content style="fixed-case" toggle="no">AE</styled-content>
s occurred when cats were on daily treatment.</p>
</sec>
<sec id="vde12018-sec-0006">
<title>Conclusions and clinical importance</title>
<p>Results suggest that the induction dose of 7 mg/kg ciclosporin can be tapered as soon as 4 weeks without deterioration of the clinical response. Establishment of the lowest effective dosing regimen of ciclosporin reduced the frequency of
<styled-content style="fixed-case" toggle="no">AE</styled-content>
s.</p>
</sec>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001087 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001087 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:7169265
   |texte=   Dose tapering for ciclosporin in cats with nonflea‐induced hypersensitivity dermatitis
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i   -Sk "pubmed:23530522" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021